Robert Crotty's Net Worth
$4.25 Thousand
Who is Robert Crotty?
Robert Crotty does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Nabriva Therapeutics plc, and DENDREON CORP.
SEC CIK
Robert Crotty's CIK is 0001600253
Past Insider Trading and Trends
2018 was Robert Crotty's most active year for acquiring shares with 3 total transactions. Robert Crotty's most active month to acquire stocks was the month of December. 2021 was Robert Crotty's most active year for disposing of shares, totalling 15 transactions. Robert Crotty's most active month to dispose stocks was the month of July. 2018 saw Robert Crotty paying a total of $44,800.00 for 132,500 shares, this is the most they've acquired in one year. In 2014 Robert Crotty cashed out on 8,094 shares for a total of $17,350.08, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nabriva Therapeutics Plc No price found
General Counsel & Corp Secreta
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
No matching records found |
Nabriva Therapeutics plc (NBRVF) Snapshot price: $0.00001
Gen Counsel & Corp SecretaryRobert Crotty owns 41,194 units of Ordinary Shares which is worth $0.41. In the year 2017 Robert Crotty acquired a total of 160,000 shares in Nabriva Therapeutics plc at a cost of $44,800.00, Robert also disposed a total of 20,557 shares of Nabriva Therapeutics plc equalling to $29,859.83.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.09% | -37.00 |
$1.06 | -$39.22 | 41.19K |
Aug 31
| |||
Form 4
| -0.18% | -74.00 |
$1.17 | -$86.58 | 41.23K |
Aug 6
| |||
Form 4
| -0.09% | -37.00 |
$1.10 | -$40.70 | 41.3K |
Jul 31
| |||
Form 4
| -0.18% | -74.00 |
$1.27 | -$93.98 | 41.34K |
Jul 6
| |||
Form 4
| -0.09% | -37.00 |
$1.35 | -$49.95 | 41.42K |
Jun 30
| |||
Form 4
| -0.18% | -73.00 |
$1.34 | -$97.82 | 41.45K |
Jun 6
| |||
Form 4
| -0.09% | -37.00 |
$1.38 | -$51.06 | 41.53K |
May 31
| |||
Form 4
| -0.18% | -74.00 |
$1.49 | -$110.26 | 41.56K |
May 6
| |||
Form 4
| -0.09% | -37.00 |
$1.78 | -$65.86 | 41.64K |
Apr 30
| |||
Form 4
| -2.38% | -1.01K |
$2.74 | -$2,778.11 | 41.67K |
Feb 6 - Apr 6
| |||
Form 4
| -0.09% | -37.00 |
$1.66 | -$61.42 | 42.69K |
Mar 31
| |||
Form 4
| -0.09% | -38.00 |
$2.39 | -$90.82 | 42.73K |
Feb 28
| |||
Form 4
| +110.59% | 22.46K |
$2.62 | -$112.66 | 42.76K |
Jan 29 - Jan 31
| |||
Form 4
| -0.18% | -37.00 |
$2.42 | -$89.54 | 20.31K |
Dec 31
| |||
Form 4
| -0.18% | -368.00 |
$0.43 | -$157.14 | 203.44K |
Nov 30
| |||
Form 4
| -0.18% | -366.00 |
$0.50 | -$181.35 | 203.81K |
Oct 31
| |||
Form 4
| -0.18% | -366.00 |
$0.53 | -$195.08 | 204.18K |
Sep 30
| |||
Form 4
| -0.18% | -366.00 |
$0.62 | -$226.70 | 204.54K |
Aug 31
| |||
Form 4
| +3.79% | 7.49K |
$0.65 | -$2,434.33 | 204.91K |
Aug 19 - Aug 20
| |||
Form 4
| -0.19% | -366.00 |
$0.76 | -$278.16 | 197.42K |
Jul 31
| |||
Form 4
| -0.18% | -366.00 |
$0.67 | -$246.90 | 197.78K |
Jun 30
| |||
Form 4
| -0.18% | -366.00 |
$1.14 | -$417.24 | 198.15K |
May 31
| |||
Form 4
| -0.18% | -366.00 |
$0.55 | -$200.68 | 198.52K |
Apr 30
| |||
Form 4
| -0.18% | -366.00 |
$0.58 | -$210.45 | 198.88K |
Mar 31
| |||
Form 4
| -0.18% | -366.00 |
$1.35 | -$494.10 | 199.28K |
Feb 28
| |||
Form 4
| +126.36% | 105K |
—
|
—
| 188.1K |
Feb 6
| |||
Form 4
| -4.47% | -3.89K |
$1.35 | -$5,254.20 | 83.1K |
Jan 31
| |||
Form 4/A
| -14.04% | -3.80K |
$2.08 | -$7,897.76 | 23.24K |
Aug 21
| |||
Form 4
| +47.21% | 7.45K |
$2.08 | -$7,897.76 | 23.24K |
Aug 19 - Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
∞
| 10K |
$4.48 | $44,800.00 | 10K |
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
DENDREON CORP No price found
EVP, General CounselRobert Crotty owns 97,855 units of Common Stock. In the year 2014 Robert Crotty acquired a total of 60,000 shares in DENDREON CORP, Robert also disposed a total of 30,328 shares of DENDREON CORP equalling to $19,190.34.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.19% | -21.76K |
$0.08 | -$1,765.06 | 97.86K |
Feb 17
| |||
Form 4
| -0.39% | -470.00 |
$0.16 | -$75.20 | 119.62K |
Jan 31
| |||
Form 4
| -0.75% | -912.00 |
$0.14 | -$125.86 | 120.09K |
Nov 30
| |||
Form 4
| -0.39% | -472.00 |
$0.98 | -$462.32 | 121K |
Oct 31
| |||
Form 4
| -0.75% | -912.00 |
$1.36 | -$1,240.32 | 121.47K |
Aug 31
| |||
Form 4
| -0.38% | -472.00 |
$2.07 | -$977.04 | 122.39K |
Jul 31
| |||
Form 4
| -0.74% | -912.00 |
$2.16 | -$1,969.92 | 122.86K |
May 31
| |||
Form 4
| -0.37% | -459.00 |
$2.58 | -$1,184.22 | 123.77K |
Apr 30
| |||
Form 4
| +82.20% | 56.05K |
$2.88 | -$11,390.40 | 124.23K |
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |